{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:26:39Z","timestamp":1761625599102,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences Inc","doi-asserted-by":"publisher","award":["GLD18\/00102"],"award-info":[{"award-number":["GLD18\/00102"]}],"id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.dld.2022.03.013","type":"journal-article","created":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T17:36:20Z","timestamp":1649784980000},"page":"1209-1214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Comparison of non-invasive fibrosis scores to predict increased liver stiffness in the general population with unknown liver disease: Searching for the primary physician's best friend"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0125-0082","authenticated-orcid":false,"given":"Pablo","family":"Coste","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elba","family":"Llop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristie","family":"Perell\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Abad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Ferre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"Calleja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.dld.2022.03.013_bib0001","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S2468-1253(16)30081-4","article-title":"Screening for liver fibrosis in the general population: a call for action","volume":"1","author":"Gin\u00e8s","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.dld.2022.03.013_bib0002","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.dld.2022.03.013_bib0003","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2022.03.013_bib0004","article-title":"High prevalence of liver fibrosis among European adults with unknown liver disease. A population-based study","author":"Caballer\u00eda","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2022.03.013_bib0005","article-title":"Non-invasive assessment of non-alcoholic fatty liver disease: clinical prediction rules and blood-based biomarkers","author":"Vilar-Gomez","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2022.03.013_bib0006","article-title":"Diagnostic modalities for non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (nash) and associated fibrosis","author":"Younossi","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2022.03.013_bib0007","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","article-title":"EASL-ALEH clinical practice guidelines: non-invasive tests for evaluation of liver disease severity and prognosis","volume":"63","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2022.03.013_bib0008","article-title":"Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)","volume":"10","author":"T","year":"2009","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.dld.2022.03.013_bib0009","first-page":"24","article-title":"Elastograf\u00eda de transici\u00f3n como m\u00e9todo de cribado de enfermedad hep\u00e1tica cr\u00f3nica en poblaci\u00f3n aparentemente sana. Resultados a partir de la cohorte ETHON","volume":"41","author":"Llop","year":"2018","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2022.03.013_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2019.08.019","article-title":"Transient elastography for screening of liver fibrosis: cost-effectiveness analysis from six prospective cohorts in Europe and Asia","author":"Serra-Burriel","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2022.03.013_bib0011","article-title":"2018 practice guidelines for the management of arterial hypertension of the European society of cardiology and the European society of hypertension ESC\/ESH task force for the management of arterial hypertension","author":"Williams","year":"2018","journal-title":"J Hypertens"},{"journal-title":"Diabetes Care","article-title":"Classification and diagnosis of diabetes: standards of medical care in Diabetesd2018","year":"2018","key":"10.1016\/j.dld.2022.03.013_bib0012"},{"journal-title":"Circulation","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","year":"2002","key":"10.1016\/j.dld.2022.03.013_bib0013"},{"key":"10.1016\/j.dld.2022.03.013_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2016.12.022","article-title":"Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis","author":"Karlas","year":"2017","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.dld.2022.03.013_bib0015","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S2468-1253(16)30205-9","article-title":"Prevalence of clinically significant liver disease within the general population, as defined by non-invasive markers of liver fibrosis: a systematic review","volume":"2","author":"Harris","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2022.03.013_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(14)61838-9","article-title":"Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis","author":"Williams","year":"2014","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.dld.2022.03.013_bib0017","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1136\/gut.2010.216077","article-title":"Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease","volume":"59","author":"McPherson","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.dld.2022.03.013_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2017.02.031","article-title":"Diagnostic accuracy of noninvasive fibrosis scores in a population of individuals with a low prevalence of fibrosis","author":"Mahady","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.dld.2022.03.013_bib0019","doi-asserted-by":"crossref","first-page":"e632","DOI":"10.5812\/hepatmon.63227","article-title":"Fatty liver index (FLI) in predicting non-alcoholic fatty liver disease (NAFLD)","volume":"18","author":"Dehnavi","year":"2018","journal-title":"Hepat Mon"},{"key":"10.1016\/j.dld.2022.03.013_bib0020","doi-asserted-by":"crossref","DOI":"10.20517\/mtod.2021.08","article-title":"The Fatty liver Index (FLI) 15 years later: a reappraisal","author":"Lonardo","year":"2021","journal-title":"Metab Target Organ Damage"},{"issue":"2","key":"10.1016\/j.dld.2022.03.013_bib0021","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.dld.2022.03.013_bib0022","doi-asserted-by":"crossref","DOI":"10.2147\/DMSO.S189544","article-title":"The fatty liver index, a simple and useful predictor of metabolic syndrome: analysis of the Korea national health and nutrition examination survey 2010\u20132011","author":"Khang","year":"2019","journal-title":"Diabetes, Metab Syndr Obes Targets Ther"},{"key":"10.1016\/j.dld.2022.03.013_bib0023","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL\u2013EASD\u2013EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2022.03.013_bib0024","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","author":"Chalasani","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2022.03.013_bib0025","article-title":"Community-based lifestyle modification programme for non-alcoholic fatty liver disease: a randomized controlled trial","author":"W","year":"2013","journal-title":"J Hepatol"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865822002183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865822002183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:19:09Z","timestamp":1761625149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865822002183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S1590865822002183"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2022.03.013","relation":{},"ISSN":["1590-8658"],"issn-type":[{"type":"print","value":"1590-8658"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of non-invasive fibrosis scores to predict increased liver stiffness in the general population with unknown liver disease: Searching for the primary physician's best friend","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2022.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}